Study of PV in Combination With Bendamustine and Rituximab for Patients With R/R MCL
Clinical trial NCT04913103 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04913103
- Sponsor
- Czech Lymphoma Study Group
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2026-08-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.